We are live on ! Find out more
Nicholas Company

Nicholas Company Portfolio holdings

AUM $5.47B Turnover 6.8%
1-Year Est. Return 16.96%
This Fund
S&P 500
This Quarter Est. Return
+3.67%
1 Year Est. Return
+16.96%
3 Year Est. Return
+65.72%
5 Year Est. Return
+94.16%
10 Year Est. Return
+404.17%
AUM
$4.5B
AUM Growth
+$94.9M
Cap. Flow
-$25.6M
Cap. Flow %
-0.57%
Top 10 Hldgs %
21.03%
Holding
225
New
17
Increased
85
Reduced
77
Closed
10
Avg Time Held
2.2 years
Top 10 Avg Time Held
1.6 years
Top 20 Avg Time Held
1.7 years

Top Buys

Rank Stock Value
1
FAST icon
Fastenal
FAST
+$35.3M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$21M
3
KDP icon
Keurig Dr Pepper
KDP
+$20.3M
4
EFX icon
Equifax
EFX
+$17.3M
5
EWBC icon
East-West Bancorp
EWBC
+$13.4M

Top Sells

Rank Stock Value
1
DVA icon
DaVita
DVA
+$42.1M
2
GWW icon
W.W. Grainger
GWW
+$41.1M
3
ABBV icon
AbbVie
ABBV
+$35.2M
4
SWKS icon
Skyworks Solutions
SWKS
+$25.8M
5
PNRA
Panera Bread Co
PNRA
+$11.9M

Sector Composition

Rank Sector Weight
1 Healthcare 21.03%
2 Technology 17.98%
3 Financials 15.03%
4 Industrials 14.79%
5 Consumer Discretionary 13.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
REGN icon
51
Regeneron Pharmaceuticals
REGN
$82.4B
$30.8M 0.68%
62,680
+48,095
+330% +$21M
2013 Q3
15 quarters
MRK icon
52
Merck
MRK
$363B
$29.6M 0.66%
484,398
+3,558
+0.7% +$217K
2016 Q4
2 quarters
NTRS icon
53
Northern Trust
NTRS
$30.1B
$28.6M 0.64%
294,545
– –
2016 Q1
5 quarters
CRM icon
54
Salesforce
CRM
$201B
$28.6M 0.64%
329,860
+1,885
+0.6% +$164K
2016 Q3
3 quarters
CAH icon
55
Cardinal Health
CAH
$58.4B
$26.9M 0.6%
345,115
– –
2013 Q2
16 quarters
LHX icon
56
L3Harris
LHX
$44.9B
$24.1M 0.54%
220,950
+25
+0% +$2.75K
2015 Q4
6 quarters
MCHP icon
57
Microchip Technology
MCHP
$39.6B
$21.5M 0.48%
557,110
-106,400
-16% -$4.18M
2013 Q2
16 quarters
RMD icon
58
ResMed
RMD
$33.9B
$19.9M 0.44%
255,020
-5,110
-2% -$366K
2014 Q1
13 quarters
KDP icon
59
Keurig Dr Pepper
KDP
$46.2B
$19.8M 0.44%
+216,925
New +$20.3M
2017 Q2
0 quarters
TFX icon
60
Teleflex
TFX
$5.36B
$17.4M 0.39%
83,760
-9,270
-10% -$1.86M
2013 Q2
16 quarters
WP
61
DELISTED
Worldpay, Inc.
WP
$17.3M 0.38%
272,945
+7,140
+3% +$448K
2013 Q2
16 quarters
PNC icon
62
PNC Financial Services
PNC
$86.3B
$16.4M 0.37%
131,485
-2,500
-2% -$302K
2013 Q2
16 quarters
MIDD icon
63
Middleby
MIDD
$4.89B
$16.3M 0.36%
133,945
+85,020
+174% +$11.2M
2013 Q2
16 quarters
WBS icon
64
DELISTED
Webster Financial
WBS
$16.2M 0.36%
309,735
+25,585
+9% +$1.29M
2016 Q2
4 quarters
CNS icon
65
Cohen & Steers
CNS
$3.49B
$16.1M 0.36%
398,005
+200
+0.1% +$7.97K
2017 Q1
1 quarter
AVNT icon
66
Avient
AVNT
$3.56B
$16.1M 0.36%
415,360
– –
2016 Q3
3 quarters
FIS icon
67
Fidelity National Information Services
FIS
$18.8B
$15.5M 0.34%
181,660
+35,855
+25% +$3M
2016 Q2
4 quarters
CPAY icon
68
Corpay
CPAY
$26.5B
$14.5M 0.32%
100,725
+20,290
+25% +$2.9M
2013 Q2
16 quarters
EWBC icon
69
East-West Bancorp
EWBC
$17.3B
$14.3M 0.32%
+243,630
New +$13.4M
2017 Q2
0 quarters
WAB icon
70
Wabtec
WAB
$48.4B
$13.8M 0.31%
150,895
– –
2013 Q2
16 quarters
VRSK icon
71
Verisk Analytics
VRSK
$24.4B
$13.6M 0.3%
160,910
+4,970
+3% +$402K
2016 Q1
5 quarters
IHS icon
72
DELISTED
IHS INC CL-A COM STK
IHS
$13.5M 0.3%
306,258
+120
+0% +$5.29K
2013 Q2
16 quarters
FBIN icon
73
Fortune Brands Innovations
FBIN
$4.74B
$13.5M 0.3%
241,266
+82
+0% +$4.44K
2014 Q2
12 quarters
OPLN icon
74
Openlane
OPLN
$4.54B
$13.4M 0.3%
844,198
-740
-0.1% -$12K
2013 Q2
16 quarters
SCI icon
75
Service Corp International
SCI
$11.1B
$13.4M 0.3%
400,350
+25,345
+7% +$807K
2016 Q3
3 quarters
1 2
3
4 5

Similar funds

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
EFG International
EFG International Zurich $5.46B AUM
Antipodes Partners
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Exor N.V.
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Voleon Capital Management
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
Glenview Capital Management
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
TD Private Client Wealth
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

Nicholas Company's Q2 2017 Portfolio in Review

As of Q2 2017, Nicholas Company held 225 positions worth $4.5B, up 2.2% from $4.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nicholas Company's Q2 2017 filing shows 17 new, 85 increased, 77 reduced and 10 closed positions. Its largest new stake was Keurig Dr Pepper: 216,925 shares worth $19.8M. The largest sale was DaVita, an estimated $42.1M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Technology and Financials.

  • Nicholas Company's largest Q2 2017 buy was Keurig Dr Pepper: 216,925 shares worth $19.8M.
  • Nicholas Company added most to Fastenal in Q2 2017, an estimated $35.3M increase.
  • Nicholas Company's biggest Q2 2017 reduction was DaVita, cutting an estimated $42.1M.
  • Nicholas Company fully exited AbbVie in Q2 2017, selling an estimated $35.2M.
  • Nicholas Company's ten largest holdings make up 21% of its $4.5B portfolio in Q2 2017.
  • Nicholas Company opened 17 new positions and closed 10 in Q2 2017.
  • Nicholas Company's portfolio value rose 2.2% quarter-over-quarter to $4.5B.

Based on Nicholas Company's 13F filing for Q2 2017, filed 11 Aug 2017.